Belite Bio (BLTE) Intangibles (2024 - 2025)
Belite Bio (BLTE) recorded quarterly Intangibles of $19000.0 in Q4 2025, down 20.83% quarter-over-quarter from $24000.0 in Q3 2025, and down 38.71% on a YoY basis from $31000.0 in Q4 2024.
Belite Bio (BLTE) Intangibles (2024 - 2025) Analysis & Trends
Belite Bio's Intangibles history runs 2 years deep, the most recent figure standing at $19000.0 for Q4 2025.
- In Q4 2025, Intangibles fell 38.71% year-over-year to $19000.0; the TTM figure through Dec 2025 stood at $19000.0 (down 38.71% YoY), while the FY2025 annual figure was $19000.0, down 38.71% from the prior year.
- Intangibles was $19000.0 for Q4 2025 at Belite Bio, down from $24000.0 in the prior quarter.
- In the past five years, Intangibles ranged from a high of $31000.0 in Q4 2024 to a low of $19000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 1.29 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Dec 31, 2024 | 31,000.00 |